Target intelligence / Profile preview

Sialic acid binding immunoglobulin-like lectin 29, pseudogene (SIGLEC29P)

Target
SIGLEC29P
Molecular classification
Pseudogene, Immunoglobulin superfamily (by homology), Lectin-related (by family nomenclature)
01

Overview

Sialic acid binding immunoglobulin-like lectin 29, pseudogene (SIGLEC29P) is a human pseudogene that is homologous to the SIGLEC family of sialic acid-binding immunoglobulin-like lectins, which are found on immune cells and typically function as cell surface receptors involved in cell-cell interactions and the immune response[1][5]. As a pseudogene, SIGLEC29P does not encode a functional protein and lacks known biological functions, disease associations, or drug interactions[1][5]. Key details: - SIGLEC29P is annotated as a pseudogene in authoritative genomic databases and lacks evidence of being a receptor, enzyme, or other druggable target[1][5]. - There are no known protein products, physiological functions, or disease associations reported for this pseudogene[1][5]. - It is sometimes referenced by the alias SIGLECP13[5]. This target is best categorized as a non-coding pseudogene and not an active molecular target in human physiology or pharmacology.

Other names
SIGLECP13

Beyond the preview

Go deeper on Sialic acid binding immunoglobulin-like lectin 29, pseudogene (SIGLEC29P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid binding immunoglobulin-like lectin 29, pseudogene (SIGLEC29P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call